CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL P15260-1 GLY 000040 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)
Protein:

INGR1 HUMAN

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

human proteoform glycosylation sites unicarbkb.csv

File (Entity type)
Description:Information for protein P15260-1 in the context of file GLY_000040
Creation Time:2026-03-02 19:56:34.000000
Results found

Linked to

 

Label

Description

 

Compound

GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]b-GlcNAc

Compound (Entity type)

A Compound

Protein

INGR1 HUMAN

Protein (Entity type)

Interferon gamma receptor 1 (precursor)

Post Translational Modification

p15260-1 179asn 179asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Compound

Man4GlcNAc2-II

Compound (Entity type)

A Compound

Post Translational Modification

p15260-1 79asn 79asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p15260-1 86asn 86asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p15260-1 34asn 34asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Compound

GlcNAc(b1-2)Man(a1-3)[Man(a1-3)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc

Compound (Entity type)

A Compound

  • Compound

    GlcNAc(b1-2)Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]b-GlcNAc

    Compound (Entity type)

    A Compound

  • Protein

    INGR1 HUMAN

    Protein (Entity type)

    Interferon gamma receptor 1 (precursor)

  • Post Translational Modification

    p15260-1 179asn 179asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Compound

    Man4GlcNAc2-II

    Compound (Entity type)

    A Compound

  • Post Translational Modification

    p15260-1 79asn 79asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    p15260-1 86asn 86asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Post Translational Modification

    p15260-1 34asn 34asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

  • Compound

    GlcNAc(b1-2)Man(a1-3)[Man(a1-3)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc

    Compound (Entity type)

    A Compound

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.